The dental space is continuing to attract private equity investment, as industry fragmentation, demographic trends and provisions of the Affordable Care Act combine to make it particularly well suited for the PE operational improvement playbook.

Cleveland Clinic Innovations has a vehicle for private equity investors to be part of a number of healthcare innovations all at once, maximizing the potential for profit, says Dr. Thomas Graham.

David Chase, founder of Rosetium, talks about what disruptions have already occurred in healthcare, and outlines other areas ripe for a change

Dave Chase, a senior advisor to Cascadia Capital for healthcare and digital health, draws parallels between those late to adapt to changes in the newspaper and healthcare industries.

Consolidation on both the provider and payer side is a continuing trend in healthcare, says Chris Harris of FFL Partners.

Chris Harris of FFL Partners explains why investing in the dental industry is recession-proof.

Chris Harris of FFL Partners talks about its investment in Clarkson Eyecare, and how performance is being measured.

The founder of Avado, a digital messaging system for the healthcare sector, talks about its acquisition by WebMD and how it is being used across multiple platforms.

Demand for private healthcare is growing rapidly in Sri Lanka, and the government is supportive of private capital investments. Asanka Rodrigo of PE firm Actis discusses a recent hospital exit in the country.

Dr. Thomas Graham, chief innovation officer at Cleveland Clinic, explains how it has turned healthcare innovations into profit for investors.

What one pharma executive thinks about the Daraprim drug pricing controversy.

The Florida-based firm closed its latest fund in October and is already putting capital to work, says partner Roger Marrero.

Attendees to Privcap’s Nov. 18 Healthcare Game Change event in New York were treated to a procession of thought leaders who shared visions of future care revolutionized in partnership with private capital.

The former co-head of healthcare investment banking at JPMorgan, Ravi Sachdev, now a partner at private equity giant Clayton, Dubilier & Rice, discusses potential disruptors in the healthcare industry.

Mark Harris of Jenner & Block discusses how to handle healthcare data in the age of the Affordable Healthcare Act.

The stunning turnaround of NPS Pharma, as told by the CEO who recently sold the company for $5.3B.

With a $5M investment, the PE firm is looking to create efficiencies in medical records distribution. General partner Brian Murphy explains the attraction to Verisma, and its potential expansion.

Veteran investor Steve Wise of The Carlyle Group will share his perspective on the private equity opportunity in a rapidly transforming economic sector at the upcoming Healthcare Game Change conference.